HealthQuill Articles by: HealthQuill
The World Health Organization, after seven years, has updated its pathogens list which has 15 families of antibiotic-resistant bacteria grouped into critical, high and medium categories for prioritisation.
Drugs Health Pharma

WHO deletes five pathogen-antibiotic combinations in new list, adds four

The World Health Organization, after seven years, has updated its pathogens list which has 15 families of antibiotic-resistant bacteria grouped into critical, high

Read More
Takeda Pharmaceutical’s subsidiary, Shire Plc., was granted an FDA nod for making generic chewable tablets to treat attention-deficit, hyperactivity disorder, and moderate to severe binge disorder in adults.
Drugs Health Medical

Vitamin D deficiency linked to cardiovascular, CKD morbidity

HQ Team May 20, 2024: Vitamin D deficiency is associated with poor outcomes in cardiovascular diseases and chronic kidney disease (CKD) in patients with early-stage

Read More
AstraZeneca plans to build a $1.5 billion facility to make antibody-drug conjugates in Singapore, the company announced in a statement.
Drugs Health Pharma

AstraZeneca plans to build $1.5 billion drug making facility in Singapore 

HQ Team May 20, 2024: AstraZeneca plans to build a $1.5 billion facility to make antibody-drug conjugates in Singapore, the company announced in

Read More
More than 1,700 people have died globally due to cholera in the four months ended April amid a shortage of vaccines because of a rise in demand, according to the World Health Organization, which has classified the outbreak as an emergency.
Drugs Health Pharma

Cholera kills 1,766 people in Jan-April period, vaccines in short supply 

HQ Team May 17, 2024: More than 1,700 people have died globally due to cholera in the four months ended April amid a

Read More
A measles vaccine given to a child born by caesarean section is likely to be 2.6 times completely ineffective than a normal delivery, a study by the University of Cambridge found.
Drugs Health Pharma

Birth by C-section may double the chance of measles vaccine failure

HQ Team May 17, 2024: A measles vaccine given to a child born by caesarean section is likely to be 2.6 times completely

Read More
The US Food and Drug Administration has cleared Amgen’s drug to treat adult patients in the extensive stages of small cell lung cancer (ES-SCLC) with disease progression on or after chemotherapy.
Drugs Health Pharma

USFDA gives nod to Amgen’s therapy for treating small cell lung cancer 

HQ Team May 17, 2024: The US Food and Drug Administration has cleared Amgen’s drug to treat adult patients in the extensive stages

Read More
Johnson & Johnson will acquire Proteologix, Inc., a privately-held biotechnology company, for $850 million in cash, according to a statement.
Drugs Health Pharma

Johnson & Johnson to buy Proteologix Inc., for $850 million in cash

HQ Team May 17, 2024: Johnson & Johnson will acquire Proteologix, Inc., a privately-held biotechnology company, for $850 million in cash, according to

Read More
Biogen, a US-based biotechnology company, will discontinue the development and commercialisation of its Alzheimer’s treatment and terminate its post-approval study as it failed to rope in a partner to cut costs of obtaining standard regulatory approval.
Climate Health Medical

Climate change impacting migraine frequency and intensity

HQ Team May 16, 2024: Migraine is a debilitating condition that affects people both mentally and physically. Recent statistics show that the frequency

Read More
Maternal deaths have risen or stagnated globally over recent years, and every two minutes, a woman dies during pregnancy or childbirth, according to the WHO.
Drugs Health Pharma

Labcrop unveils new blood test to predict preeclampsia early in pregnant women

HQ Team May 16, 2024: Preeclampsia is a serious hypertensive complication of pregnancy that affects roughly 2% to 8% of pregnant women worldwide.

Read More
The World Health Organization has prequalified a dengue vaccine for children made by Japan’s Takeda Pharmaceutical Company — the third-largest drug firm in Asia.
Drugs Health Pharma

WHO prequalifies Japan-based Takeda’s dengue vaccine for children

HQ Team May 15, 2024: The World Health Organization has prequalified a dengue vaccine for children made by Japan’s Takeda Pharmaceutical Company —

Read More